Multi-centre randomised controlled trial for postnatal depression in British South Asian women - ROSHNI-2

ISRCTN ISRCTN10697380
DOI https://doi.org/10.1186/ISRCTN10697380
Secondary identifying numbers CPMS 32313
Submission date
23/01/2017
Registration date
26/01/2017
Last edited
21/03/2025
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Postnatal depression (PND) is a type of depression that some mothers experience after having a baby. It can cause disability and suffering in women, negative consequences for their infants and their family with huge costs to society. Rates of PND in British South Asian (BSA) women are higher than the general population. Due to language and cultural barriers, BSA women often do not access appropriate health care services. This has been highlighted as a major contributor to unequal healthcare across the UK populations. Mothers of South-Asian backgrounds (Bangladesh, Pakistan and India) account for a large number of births in the UK. There is a growing concern about ethnic inequalities in the provision and access to postnatal depression services, which is an identified priority in both England and Scotland. The Positive Health Programme (PHP) is a new culturally adapted treatment program that has been developed to help women with PND. Smaller studies have shown that it may lead to improved mood, and successfully engages and supports women from a South Asian background. The aim of this study is to look at the effectiveness and cost-effectiveness of PHP in the treatment of BSA women with PND.

Who can participate?
British women of South Asian origin with PND who have had a baby within the last year.

What does the study involve?
Participants are randomly allocated to one of two groups. Those in the first group receive the PHP programme as well as standard treatment. This involves 12 group sessions which last for 60-90 minutes every week for two months and then fortnightly for a further two months. The sessions involve learning life skills and having the opportunity to meet other women in similar circumstances. Those in the second group receive usual care only. At the start of the study and then after four and 12 months, participants in both groups complete a questionnaire to measure their depression levels. At the end of the study, the costs of delivering the programme are also calculated from questionnaires completed by participants at the start of the study and after four and 12 months.

What are the possible benefits and risks of participating?
Participants who receive the programme may benefit from improvements to their mood. There are no major risks involved with participants, although some women may find taking about experiences and feelings to be difficult.

Where is the study run from?
Lancashire and South Cumbria NHS Foundation Trust (UK)

When is the study starting and how long is it expected to run for?
July 2016 to August 2022

Who is funding the study?
National Institute for Health Research (UK) - HTA programme

Who is the main contact?
1. Dr Farah Lunat - project manager
farah.lunat@lscft.nhs.uk
2. Professor Nusrat Husain (scientific)
nusrat.husain@manchester.ac.uk

Contact information

Dr Farah Lunat
Public

Lantern Centre
Vicarage Lane
Fulwood
Preston
PR2 8DW
United Kingdom

ORCiD logoORCID ID 0000-0003-4091-6139
Phone +44 (0)1772 773498
Email farah.lunat@lscft.nhs.uk
Prof Nusrat Husain
Scientific

University of Manchester & Lancashire Care NHS Foundation Trust
3rd Floor, Jean Mcfarlane Building University of Manchester
Oxford Road
Manchester
M13 9PL
United Kingdom

Phone +44 (0)161 306 7921
Email nusrat.husain@manchester.ac.uk

Study information

Study designRandomized; Interventional; Design type: Treatment, Screening, Diagnosis, Psychological & Behavioural
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Charity/Voluntary sector, Community, GP practice, Medical and other records
Study typeTreatment
Participant information sheet ISRCTN10697380_PIS_01Jul16_V1.docx
Scientific titleMulti Centre RCT of a group psychOlogical intervention for poStnatal depression in britisH mothers of south asiaN origIn - ROSHNI-2
Study acronymROSHNI-2
Study objectivesThe aim of this study is to investigate the clinical and cost-effectiveness of a culturally adapted group psychological intervention called the Positive Health Programme (PHP) in British South Asian (BSA) women with post-natal depression.

Added 16/09/2022:
An add-on study was included in August 2021. The aim of this additional work is to explore and understand the wider consequences of the global pandemic on BSA women during the perinatal period in the context of mental health, isolation, education, interpersonal relationships, child development and views on the vaccination and wider impacts. The pandemic has resulted in the closure of parent support groups including baby play, breastfeeding support and child health clinic drop-in sessions. The researchers will also explore the nature and intensity of breastfeeding problems encountered, help-seeking behaviours and sources of support.
Ethics approval(s)Approved 06/01/2017, North West - Greater Manchester South Research Ethics Committee (3rd Floor, Barlow House 4 Minshull Street, Manchester, M1 3DZ, United Kingdom; +44 (0)207 104 8235; nrescommittee.northwest-gmsouth@nhs.net), ref: 16/NW/0727
Health condition(s) or problem(s) studiedPostnatal depression, maternal mental health, interpersonal violence
InterventionConsenting, eligible women will be randomized via an independent remote randomisation service based at the King's College Clinical trials unit (CTU). After each block of 18 women have been recruited into the trial in each centre, women will be block randomised to the two treatments to give 9 intervention and 9 control participants.

Intervention: Participants receive a CBT-based culturally adapted group psychological intervention called the Positive Health Programme (PHP) added to the Treatment As Usual. The manual assisted intervention PHP has been designed to be delivered by non-specialist mental health professionals. The 12 groups/sessions are educational life skills classes, based on a CBT model. Each PHP session will last for 60-90 minutes and will be delivered weekly for two months, and then fortnightly for further two months.

Treatment as usual (TAU): Participants undergo study assessments along with routine assessment and management as usually conducted by the participating general practices.

The assessments for both the arms will be at baseline, at 4 months (end of intervention) and then 12 months after baseline. The duration of the assessment will not be more than 45-60 minutes.

Added 16/09/2022:
An additional work stream was included in November 2021 as an add-on study to the ROSHNI-2 project (14/68/08, HTA). The proposed work is shaped by the suggestions made by participants in the current ROSHNI-2 study for a follow-up and re-engagement to explore other associated risk factors related to maternal mental health and specifically in the context of the pandemic. We aim to increase our understanding of the pandemic-related impact on BSA women including Interpersonal Violence (IPV) in BSA communities. The add-on study is supported by an ongoing MRC-funded international survey study - Psychological impact of COVID-19 pandemic and experience: An International Survey (IRAS Project ID 282858). The project is led by Southern Health NHS Foundation Trust and The University of Portsmouth. It aims to investigate and explore the psychological impact of COVID-19, the resultant restrictions and the impact on behaviours and changes in mental wellbeing across the global population.
Intervention typeOther
Primary outcome measureRecovery from postnatal depression is measured using the Hamilton Depression Rating Scale (HDRS) at 4 months (end of intervention)
Secondary outcome measures1. Treatment response is measured using the Hamilton Depression Rating Scale (HDRS) at baseline, 4 and 12 months
2. Cost data will be collected using an Economic Patient Questionnaire at baseline, 4 and 12 months
Overall study start date01/07/2016
Completion date26/08/2022

Eligibility

Participant type(s)Patient, Service user
Age groupAdult
Lower age limit16 Years
SexFemale
Target number of participantsPlanned Sample Size: 720; UK Sample Size: 720
Total final enrolment732
Key inclusion criteria1. Self-ascribed British women of South Asian origin as defined by Office of National Statistics (ONS, 2011)
2. Over the age of 16 years and living with their infants up to the age of 12 months (1-Year)
3. Meet the criteria for DSM-V depression
Key exclusion criteria1. Women with diagnosed learning disability that will impact on capacity to consent
2. Postpartum psychosis
3. Any other diagnosed psychosis
4. Actively suicidal (previous history of self-harm or suicide attempt).
Date of first enrolment08/02/2017
Date of final enrolment26/08/2022

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Lancashire and South Cumbria NHS Foundation Trust
The Lantern Centre
Vicarage Lane
Preston
PR2 8DW
United Kingdom

Sponsor information

Lancashire Care NHS Foundation Trust
Hospital/treatment centre

Sceptre Point
Sceptre Way
Bamber Bridge
Preston
PR5 6AW
England
United Kingdom

ROR logo "ROR" https://ror.org/03zefc030

Funders

Funder type

Government

National Institute for Health Research
Government organisation / National government
Alternative name(s)
National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
Location
United Kingdom

Results and Publications

Intention to publish date01/09/2024
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryOther
Publication and dissemination planCurrent publication and dissemination plan as of 10/07/2024:
The study protocol has been published (https://doi.org/10.1192/bjo.2021.1032). The full study report is being published in the NIHR HTA journal https://www.journalslibrary.nihr.ac.uk/hta/#/ in September 2024.

Further planned publication in high-impact peer-reviewed journals at the end of the recruitment and final results in the year 2024.

An output on lessons learnt and strategies from this trial is attached for wider sharing.

Previous publication and dissemination plan as of 16/09/2022:
The study protocol has been published (https://doi.org/10.1192/bjo.2021.1032). Further planned publication in high-impact peer-reviewed journals at the end of the recruitment and final results in the year 2022.

Previous publication and dissemination plan:
The study protocol will be published before the end of 2017 and there is further planned publication in high-impact peer-reviewed journals at the end of the recruitment and final results in the year 2022.
IPD sharing planThe datasets generated and/or analysed during the current study will be included in the subsequent results publication.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet version V1 01/07/2016 26/01/2017 No Yes
Protocol article 01/01/2022 16/09/2022 Yes No
HRA research summary 28/06/2023 No No
Poster results 10/07/2024 No No
Results article 12/10/2024 15/10/2024 Yes No
Other publications Economic evaluation 17/03/2025 21/03/2025 Yes No

Additional files

ISRCTN10697380_PIS_01Jul16_V1.docx
Uploaded 26/01/2017
ISRCTN10697380_ROSHNI-2 strategies poster.pdf

Editorial Notes

21/03/2025: Publication reference added.
15/10/2024: Publication reference added.
10/07/2024: The following changes were made to the study record:
1. Poster and ethics approval details added.
2. The study setting was changed from Hospital to Charity/Voluntary sector, Community, GP practice, Medical and other records.
3. Service user was added to the participant types.
4. The publication and dissemination plan was updated.
5. The intention to publish date was changed from 31/12/2022 to 01/09/2024.
16/09/2022: The following changes were made to the trial record:
1. The study hypothesis, trial participating centre details, interventions, and the publication and dissemination plan were updated.
2. The recruitment end date was changed from 30/03/2020 to 26/08/2022.
3. The overall trial end date was changed from 30/06/2021 to 26/08/2022.
4. Condition was changed from 'Postnatal depression' to 'Postnatal depression, maternal mental health, interpersonal violence'.
5. Publication reference added.
6. The total final enrolment number was changed from 733 to 732.
7. Contact details updated.
17/04/2020: The total final enrolment was added.
12/03/2020: The recruitment end date was changed from 02/03/2020 to 30/03/2020.
13/02/2020: The recruitment end date was changed from 31/12/2019 to 02/03/2020.
08/11/2019: The recruitment start date was changed from 01/11/2016 to 08/02/2017.
28/03/2019: The condition has been changed from "Specialty: Primary Care, Primary sub-specialty: Mental Health; UKCRC code/ Disease: Mental Health/ Mood [affective] disorders, Reproductive Health and Childbirth/ Other maternal disorders predominantly related to pregnancy" to "Postnatal depression" following a request from the NIHR.
04/10/2018: The following changes were made to the trial record:
1. The recruitment end date was changed from 30/08/2018 to 31/12/2019.
2. The overall trial end date was changed from 30/06/2020 to 30/06/2021.
2. The intention to publish date was changed from 31/12/2021 to 31/12/2022.